European Archives - Page 913 of 1057 - European Medical Journal

Continue
9 Mins
28 Jul 2016

Navigating the Changing Multiple Myeloma Treatment Landscape

The treatment landscape for patients with multiple myeloma (MM) is constantly evolving. Over the past decade, the introduction of novel agents including…
2 Mins
28 Jul 2016

Family-Directed Cord Blood Banking for Sickle Cell Disease: A 20-Year Experience on Behalf of Eurocord-Monacord and the International Sickle Cell Disease Observatory

Cord blood transplantation (CBT) from a related family member is an effective therapy for patients with sickle cell disease (SCD) resulting in…
9 Mins
28 Jul 2016

Editor’s Pick: Minimisation of Bleeding Risks Due to Direct Oral Anticoagulants

Direct oral anticoagulants (DOAC) are used in several indications for the prevention and treatment of thrombotic events. As highlighted by data from…
1 Mins
28 Jul 2016

Real-World Experience of Ibrutinib in More Than 700 Patients with Mantle Cell Lymphoma: Data from a Global Named Patient Programme

Mantle cell lymphoma (MCL) is an uncommon but aggressive form of B cell non-Hodgkin lymphoma. It often presents at an advanced stage and with a median…
9 Mins
28 Jul 2016

Bridging to Transplant in Diffuse Large B Cell Lymphoma

Non-Hodgkin lymphoma (NHL) is the eighth most common malignancy worldwide. Diffuse large B cell lymphoma (DLBCL) is the most frequent subtype, accounting…
9 Mins
28 Jul 2016

Thrombocytopenia Caused By Inherited Haematopoietic Transcription Factor Mutation: Clinical Phenotypes and Diagnostic Considerations

Inherited thrombocytopenias comprise a heterogeneous group of blood disorders with abnormalities in genes related to glycoproteins and adhesion molecules…
2 Mins
28 Jul 2016

The Spectrum of Late Effects After Cancer: Lessons from Paediatric Oncology and the Value of International Collaboration

This presentation described the occurrence of late side effects (commonly described as ‘late effects’) in childhood cancer survivors (CCS), and how…
1 Mins
28 Jul 2016

Chronic Lymhocytic Leukaemia: Treatment of the Elderly

Chronic lymphocytic leukaemia (CLL) mainly affects elderly patients.1 With the increasing comorbidity burden and frailty in elderly patients, evaluation…
9 Mins
28 Jul 2016

The Relative Contributions of Germline Variation, Epimutation, and Somatic Mutation to Paediatric Leukaemia Predisposition

The next-generation sequencing era has repeatedly demonstrated that the amount of acquired somatic mutations in paediatric cancers can rarely account for…
16 Mins
28 Jul 2016

Current Management of Adult Acute Lymphoblastic Leukaemia: Emerging Insights and Outstanding Questions

Less than 50% of patients with adult acute lymphoblastic leukaemia (ALL) experience long-term survival and for those adults >60 years old, long-term…